Elisabet García Rodríguez

Tècnic/a de laboratori

Grup de recerca

Equip

Elisabet García va estudiar formació professional de Tècnic Especialista de Laboratori. Després d’acabar els seus estudis, va entrar a formar part del Departament de Bioquímica de l’Hospital Clínic de Barcelona.

Posteriorment va arribar a IrsiCaixa, on ha treballat amb diversos grups: Processament de Mostres, Servei de Seqüenciació, el grup de Virologia Cel·lular i, actualment, el grup de Virologia Tissular.

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.

Revista

Antiviral therapy

Any

2010
Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.

Revista

Scientific reports

Any

2017
Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.

Revista

AIDS (London, England)

Any

2009
Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers.

Revista

AIDS (London, England)

Any

2015
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.

Revista

Antiviral therapy

Any

2008

Veure totes les publicacions

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.

Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.

Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.

Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers.

Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.